SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,866.51 |
| Enterprise Value ($M) | 4,745.67 |
| Book Value ($M) | 1,011.06 |
| Book Value / Share | 15.23 |
| Price / Book | 4.81 |
| NCAV ($M) | 991.80 |
| NCAV / Share | 14.94 |
| Price / NCAV | 4.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.30 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.48 |
| Current Ratio | 14.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,086.55 |
| Assets | 1,105.81 |
| Liabilities | 94.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -280.37 |
| Net Income | -260.76 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -185.06 |
| Cash from Investing | -573.51 |
| Cash from Financing | 568.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 4.50 | -18.68 | |
| 13G/A | Flynn James E | 27.59 | -7.81 | |
| 13G/A | Vanguard Group Inc | 6.85 | 34.73 | |
| 13G/A | Paradigm Biocapital Advisors LP | 7.80 | 29.60 | |
| 13G/A | Perceptive Advisors Llc | 4.60 | 2.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 89,586 | 327,901 | 27.32 | |
| 80,885 | 331,063 | 24.43 | |
| 36,872 | 154,978 | 23.79 | |
| 57,594 | 397,501 | 14.49 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NEOG – Neogen Corporation | NKTX – Nkarta, Inc. |
| NMRA – Neumora Therapeutics, Inc. | NVAX – Novavax, Inc. |
| NXTC – NextCure, Inc. |
Financial data and stock pages provided by
Fintel.io